Cloning and characterisation of the Anisakis simplex allergen Ani s 4 as a cysteine-protease inhibitor.
Anisakis simplex is a nematode that can parasitise humans who eat raw or undercooked fish containing live L3s. Larvae invading the gastrointestinal mucosa excrete/secrete proteins implicated in the pathogenesis of anisakiasis that can induce IgE mediated symptoms. Misdiagnosis of anisakiasis, due to cross-reactivity, makes it necessary to develop new diagnostic tools. Recombinant allergens have proved to be useful for diagnosis of other parasitoses. Among the Anisakis allergens, Ani s 4 was considered to be a good potential diagnostic protein because of its heat resistance and its importance in the clinical history of sensitised patients. Therefore, the objective of this study was to clone and characterise the cDNA encoding this allergen. The Ani s 4 mRNA sequence was obtained using a PCR-based strategy. The Ani s 4 amino acid sequence contained the characteristic domains of cystatins. Mature recombinant Ani s 4 was expressed in a bacterial system as a His-tagged soluble protein. The recombinant Ani s 4 inhibited the cleavage of a peptide substrate by papain with a Ki value of 20.6 nM. Immunobloting, ELISA, a commercial fluorescence-enzyme-immunoassay and a basophil activation test were used to study the allergenic properties of rAni s 4, demonstrating that the recombinant allergen contained the same IgE epitopes as the native Ani s 4, and that it was a biologically active allergen since it activated basophils from patients with allergy to A. simplex in a specific concentration-dependent manner. Ani s 4 was localised by immunohistochemical methods, using a polyclonal anti-Ani s 4 anti-serum, in both the secretory gland and the basal layer of the cuticle of A. simplex L3. In conclusion, we believe that Ani s 4 is the first nematode cystatin that is a human allergen. The resulting rAni s 4 retains all allergenic properties of the natural allergen, and can therefore be used in immunodiagnosis of human anisakiasis.
Rodriguez-Mahillo
Ana I
AI
Immunology Department, Hospital Carlos III, Madrid, Spain.
Gonzalez-Muñoz
Miguel
M
Gomez-Aguado
Fernando
F
Rodriguez-Perez
Rosa
R
Corcuera
Maria Teresa
MT
Caballero
Maria Luisa
ML
Moneo
Ignacio
I
D000485:Allergens / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D017129:Anisakiasis / Q000276:immunology; D017163:Anisakis / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D001491:Basophils / Q000187:drug effects; D003001:Cloning, Molecular; D015853:Cysteine Proteinase Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D015801:Helminth Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010206:Papain / Q000037:antagonists & inhibitors; D011487:Protein Conformation; D018510:RNA, Helminth
D000485:Allergens; C000603307:Ani s 4 allergen, Anisakis simplex; D015853:Cysteine Proteinase Inhibitors; D015801:Helminth Proteins; D018510:RNA, Helminth; D010206:Papain